Research is showing high hopes for cannabinoid therapy and its acceptance as a medical standard for helping elderly patients. Recently Israeli research in the European Journal of International Medicine had the opportunity to research the effectiveness of medical cannabis in patients 65 and over. The patients all had conditions ranging from Parkinson’s disease and neuropathic pain to cancer and much more.
The research conducted confirmed what millions have been telling lawmakers for decades – cannabis works! According to the study, seniors reported significant improvement in pain reduction and overall quality of life after receiving six months of cannabinoid therapy treatment.
One of the major concerns with this study was that cannabis would impair the patients motor skills prompting more falls which already are a common occurrence with the elderly. However, the opposite occurred, and the number of falls was reduced after receiving cannabis treatment.
Research shows that cannabis may also potentially play a role in improving behaviour in dementia patients. Dr. Vered Hermush is the Geriatric Wing Director for Laniado Hospital and expresses that patients with behavioural disorders as a result of dementia can be challenging to treat. Dr. Ramesh observed improvement in behavioural patterns of patients with dementia who had received cannabis treatments.
He’s even seen patients that were non-communicative begin to communicate with family members after receiving cannabinoid therapy treatments. Dr. Hermush aims to replace anecdotal reports with that of hard data in the very near future.
Cannabinoid therapy research in Israel doesn’t stop there. Another investigation is currently underway looking into the effectiveness of cannabinoids in helping to treat appetite disorders in dialysis patients. The only thing slowing down the progress of this research is bureaucratic obstacles because even in Israel where cannabis research is decades ahead, bureaucratic obstacles still stand in the way of this widely misunderstood plant.